NCT04616703

Brief Summary

The data on long term natural history of benign nonfunctioning adrenal tumors (NFATs) are lacking. The aim is to identify clinical characteristics associated with tumor growth and progression to mild autonomous cortisol excess over time.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 22, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 5, 2020

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2020

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

November 5, 2020

Status Verified

October 1, 2020

Enrollment Period

1.5 years

First QC Date

October 22, 2020

Last Update Submit

October 29, 2020

Conditions

Keywords

adrenal incidentalomaBMINFAIMACElong term follow upnatural history

Outcome Measures

Primary Outcomes (3)

  • Natural History of NFAT - horomnal activity

    To determine if and in how many pateints NFAI progressed to MACE. NFAI: when cortisol after 1 mg overnight dexamethasone (ODST) suppression test is \< 50 nmol/l and no typical clinical signs of Cushing's syndrome are present. Pheochromocytoma and primary aldosteronism will be excluded. MACE: when cortisol after 1 mg overnight dexamethasone (ODST) suppression test is \> 50 nmol/l.

    10 years

  • Natural History of NFAT - growth

    To determine the change in size of NFAI on the CT scan (mm).

    10 years

  • Natural History of NFAT - BMI

    To determine the change in BMI and its correlation with outcome 1 and 2. Weight and height will be combined to report BMI in kg/m\^2.

    10 years

Study Arms (3)

BMI < 25 kg/m2

Those with NFAT and BMI \< 25 kg/m2.

Radiation: CT imaging

BMI 25-30 kg/m2

Those with NFAT and BMI 25-30 kg/m2.

Radiation: CT imaging

BMI > 30 kg/m2

Those with NFAT and BMI \> 30 kg/m2.

Radiation: CT imaging

Interventions

CT imagingRADIATION

CT of abdomen

BMI 25-30 kg/m2BMI < 25 kg/m2BMI > 30 kg/m2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with diagnosisi of NFAI, hospitalized between 2005-2012 at the Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia.

You may qualify if:

  • \- Patients hospitalized because of NFAI between 2005-2012 at the Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia.

You may not qualify if:

  • age below 18 years
  • relatives reported that patient died in the time since hospitalization
  • patient did not want a follow up
  • patient did not attend follow up appointment
  • patient underwent adrenalectomy
  • misdiagnosis / missing main information in hospitalization record

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Ljubljana, 1000, Slovenia

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

venous blood sample

MeSH Terms

Conditions

Adrenal incidentaloma

Interventions

Postmortem Imaging

Intervention Hierarchy (Ancestors)

AutopsyDiagnostic Techniques and ProceduresDiagnosisDiagnostic ImagingInvestigative Techniques

Study Officials

  • Mojca Jensterle, MD, PhD

    University Medical Center Ljubljana, Slovenia

    STUDY DIRECTOR

Central Study Contacts

Mojca Jensterle, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 22, 2020

First Posted

November 5, 2020

Study Start

June 1, 2019

Primary Completion

November 15, 2020

Study Completion

December 1, 2020

Last Updated

November 5, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations